Potent vasopressin antagonists lacking the proline residue at position 7

Area of Science:

• Pharmacology
• Medicinal Chemistry
• Endocrinology

Background:

• Arginine-vasopressin (AVP) antagonists are crucial for treating conditions related to water balance.
• The C-terminal tripeptide of AVP antagonists is being investigated for its role in receptor binding.
• Proline at position 7 in AVP is thought to be key for agonist activity, but its role in antagonists is unclear.

Purpose of the Study:

• To determine the minimum pharmacophore requirements for vasopressin (VP) antagonist activity.
• To investigate the importance of the C-terminal tripeptide, specifically proline and glycine residues, in VP antagonist potency.
• To synthesize and evaluate analogues lacking proline and/or glycine for their antidiuretic and V2-receptor antagonist effects.

Main Methods:

• Synthesis of vasopressin antagonist analogues, specifically analogue 3 lacking proline at position 7.
• Further synthesis of analogues (4-7 and 9) lacking both proline and glycine residues.
• Evaluation of antidiuretic and V2-receptor antagonist activity of the synthesized analogues.

Main Results:

• Analogue 3, lacking proline, retained significant antidiuretic antagonist activity.
• Deletion of glycine at position 9 did not reduce VP antagonist potency.
• Analogues lacking both proline and glycine also effectively blocked vasopressin V2-receptor activity.

Conclusions:

• Neither proline nor glycine residues at positions 7 and 9, respectively, are essential for vasopressin V2-receptor antagonism.
• These findings refine the understanding of structure-activity relationships for VP antagonists.
• The study contributes to the design of potent and potentially more selective VP antagonists.